| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1962925-29-6 | Nirogacestat Hydrobromide;(2S)-2-(((2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl)imidazol-4-yl)pentanamide;dihydrobromide | C27H43Br2F2N5O |
| 1965291-08-0 | Ibrexafungerp Citrate;(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-((2R)-2-amino-2,3,3-trimethylbutoxy)-5,7,10,15-tetramethyl-7-((2R)-3-methylbutan-2-yl)-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo(13.3.3.01,14.02,11.05,10)henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid | C50H75N5O11 |
| 1966941-11-6 | Rotigotine EP Impurity I;((6R)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl) 4-methylbenzenesulfonate | C26H31NO3S2 |
| 1971007-95-0 | N-((1-(Cyclohexylmethyl)-1H-indol-3-yl)carbonyl)-3-methyl-L-valine methyl ester | C23H32N2O3 |
| 1975982-94-5 | Osimertinib Impurity M;2-(5-methoxy-N-methyl-4-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)-2-(prop-2-enoylamino)anilino)-N,N-dimethylethanamine oxide | C28H33N7O3 |
| 1980023-97-9 | (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride | C10H13Cl2FN4 |
| 1980063-54-4 | 4-(Difluoromethyl)aniline hydrochloride | C7H8ClF2N |
| 1980785-05-4 | Methanesulfonato(Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxybiphenyl-2-yl)phosphine)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) | C45H65NO5PPdS- |
| 1985606-14-1 | Baloxavir marboxil;({(12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,e)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-(1,4)oxazino(3,4-c)pyrido(2,1-f)(1,2,4)triazin-7-yl}oxy)methyl methyl carbonate; Baloxavir marboxil; S 033188; Xofluza | C27H23F2N3O7S |
| 1985607-70-2 | (12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-(1,4)oxazino(3,4-c)pyrido(2,1-f)(1,2,4)triazine-6,8-dione;(3R)-11-phenylmethoxy-5-oxa-1,2,8-triazatricyclo(8.4.0.03,8)tetradeca-10,13-diene-9,12-dione | C17H17N3O4 |
| 1985607-83-7 | 7,8-Difluoro-6,11-dihydrodibenzo(b,e)thiepin-11-ol | C14H10F2OS |
| 1987887-92-2 | Nintedanib N-Methyl aniline analog;methyl 2-hydroxy-3-(N-(4-(methylamino)phenyl)-C-phenylcarbonimidoyl)-1H-indole-6-carboxylate | C24H21N3O3 |
| 1987905-93-0 | Ibrutinib impurity 6;1,3-bis((3R)-3-(4-amino-3-(4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)propan-1-one | C47H46N12O3 |
| 1991986-30-1 | 2-(((4-Methylphenyl)sulfonyl)amino)-N-(4-phenyl-2-thiazolyl)-4-(trifluoromethyl)benzamide | C24H18F3N3O3S2 |
| 1997361-85-9 | Semaglutide Acetate;acetic acid;18-(((1S)-4-(2-(2-(2-(2-(2-(2-(((5S)-5-(((2S)-2-(((2S)-2-(((2S)-5-amino-2-((2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S,3R)-2-(((2S)-2-(((2S,3R)-2-((2-(((2S)-2-((2-(((2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl)amino)-2-methylpropanoyl)amino)-4-carboxybutanoyl)amino)acetyl)amino)-3-hydroxybutanoyl)amino)-3-phenylpropanoyl)amino)-3-hydroxybutanoyl)amino)-3-hydroxypropanoyl)amino)-3-carboxypropanoyl)amino)-3-methylbutanoyl)amino)-3-hydroxypropanoyl)amino)-3-hydroxypropanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-4-methylpentanoyl)amino)-4-carboxybutanoyl)amino)acetyl)amino)-5-oxopentanoyl)amino)propanoyl)amino)propanoyl)amino)-6-(((2S)-1-(((2S)-1-(((2S,3S)-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2S)-5-carbamimidamido-1-((2-(((2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-4-carboxy-1-oxobutan-2-yl)amino)-6-oxohexyl)amino)-2-oxoethoxy)ethoxy)ethylamino)-2-oxoethoxy)ethoxy)ethylamino)-1-carboxy-4-oxobutyl)amino)-18-oxooctadecanoic acid | C189H295N45O61 |
| 2002381-31-7 | 6,7-Dimethoxy-N-(2-methyl-4-phenoxyphenyl)-4-quinazolinamine hydrochloride (1:1) | C23H21N3O3.HCl |
| 2004659-83-8 | Sorafenib Related Compound 11;N-methyl-4-(4-(2-(methylcarbamoyl)pyridin-4-yl)oxyanilino)pyridine-2-carboxamide | C20H19N5O3 |
| 2004659-84-9 | Sorafenib EP Impurity B;4-(4-(Formylamino)phenoxy)-N-methyl-2-pyridinecarboxamide | C14H13N3O3 |
| 2007924-97-0 | Methyl (3R,5S)-rel-5-(trifluoromethyl)piperidine-3-carboxylate HCl | C8H13ClF3NO2 |
| 2009020-38-4 | (2'-(amino-κN)(1,1'-biphenyl)-2-yl-κC)(bis(1,1-dimethylethyl)(3-methoxy-6-methyl-2',4',6'-tris(1-methylethyl)(1,1'-biphenyl)-2-yl)phosphine-κP)(methanesulfonato-κO)-Palladium;RockPhos Pd G3 | C44H62NO4PPdS |
| 2009273-71-4 | 6'-Amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-(3,3'-bipyridine)-6-carboxamide | C20H20N4O2 |
| 2012607-27-9 | N-(1,1-Dimethylethyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)-2-pyridinyl)-4-piperidinyl)-1H-imidazole-5-carboxamide;WNK 463 | C21H24F3N7O2 |
| 2023006-41-7 | t-Butyl (4S)-4-(methoxymethyl)-2,2-dioxo-oxathiazolidine-3-carboxylate | C9H17NO6S |
| 2023788-19-2 | Tirzepatide;LY 3298176; LY3298176; 20-((4-(2-(2-(2-(2-(2-(2-((5-((5-amino-2-(2-((2-((6-amino-2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-amino-3-(4-hydroxyphenyl)propanoyl)amino)-2-methylpropanoyl)amino)-4-carboxybutanoyl)amino)acetyl)amino)-3-hydroxybutanoyl)amino)-3-phenylpropanoyl)amino)-3-hydroxybutanoyl)amino)-3-hydroxypropanoyl)amino)-3-carboxypropanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-hydroxypropanoyl)amino)-3-methylpentanoyl)amino)-2-methylpropanoyl)amino)-4-methylpentanoyl)amino)-3-carboxypropanoyl)amino)hexanoyl)amino)-3-methylpentanoyl)amino)propanoylamino)-5-oxopentanoyl)amino)-6-((1-((1-((1-((5-amino-1-((1-((1-((1-((1-((2-((2-(2-((1-((1-((2-((1-(2-(2-(2-((1-amino-3-hydroxy-1-oxopropan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)pyrrolidine-1-carbonyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-oxoethyl)amino)-2-oxoethyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-1,5-dioxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-6-oxohexyl)amino)-2-oxoethoxy)ethoxy)ethylamino)-2-oxoethoxy)ethoxy)ethylamino)-1-carboxy-4-oxobutyl)amino)-20-oxoicosanoic acid | C225H348N48O68 |
| 2029049-79-2 | N-(3-oxo-3-(((1R)-1,2,3,4-tetrahydro-1-naphthalenyl)amino)propyl)-4-(trifluoromethoxy)-benzamide | C21H21F3N2O3 |
| 2029205-64-7 | 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo(3,4-c)pyridine-3-carboxamide | C24H22ClN5O3 |
| 2030182-41-1 | 3-(3-Chloro-4-methoxyphenyl)-1,1-bis((2H3)methyl)urea | C10H7D6ClN2O2 |
| 2030242-21-6 | Enzalutamide Impurity 7;Enzalutamide metabolite M7;4-(3-(3-fluoro-4-(methylcarbamoyl)phenyl)-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl)-2-(trifluoromethyl)benzamide | C21H18F4N4O3S |
| 2031255-23-7 | Ibrutinib dimer;1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)-3-((3-(4-phenoxyphenyl)-1-((3R)-1-prop-2-enoylpiperidin-3-yl)pyrazolo(3,4-d)pyrimidin-4-yl)amino)propan-1-one | C50H48N12O4 |
| 2036272-55-4 | 1,1'-(((4-Hydroxybutyl)imino)di-6,1-hexanediyl) bis(2-hexyldecanoate);ALC-0315 | C48H95NO5 |
| 2040291-27-6 | (2R,3R,4S,5R)-2-(4-aminopyrrolo(2,3-d)pyrimidin-7-yl)-5-((R)-hydroxy(phenyl)methyl)oxolane-3,4-diol | C17H18N4O4 |
| 2040295-03-0 | Pexidartinib Hydrochloride;5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine;hydrochloride | C20H16Cl2F3N5 |
| 2044702-38-5 | Fmoc-N-Me-Dab(Boc)-OH;2-(9H-fluoren-9-ylmethoxycarbonyl(methyl)amino)-4-((2-methylpropan-2-yl)oxycarbonylamino)butanoic acid | C25H30N2O6 |
| 2044702-39-6 | Osimertinib Impurity G;N-(2-(Dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | C25H26N6O2 |
| 2044709-88-6 | N2-((1,1-Dimethylethoxy)carbonyl)-N6-((9H-fluoren-9-ylmethoxy)carbonyl)-N2-methyl-D-lysine | C27H34N2O6 |
| 2044710-35-0 | N6-((1,1-Dimethylethoxy)carbonyl)-N2-methyl-D-lysine methyl ester hydrochloride (1:1) | C13H26N2O4.HCl |
| 2044710-37-2 | N-Methyl-D-norleucine hydrochloride (1:1) | C7H15NO2.HCl |
| 2044710-64-5 | N5-((1,1-Dimethylethoxy)carbonyl)-N2-((9H-fluoren-9-ylmethoxy)carbonyl)-N2-methyl-D-ornithine | C26H32N2O6 |
| 2045402-27-3 | alpha Hydroxy montelukast;2-(1-(((1R)-1-(3-((E)-2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)sulfanylmethyl)cyclopropyl)-2-hydroxyacetic acid | C35H36ClNO4S |
| 2049025-67-2 | Carfilzomib Impurity 12;(S)-4-Methyl-N-((S)-1-(((R)-4-Methyl-1-((S)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide | C40H57N5O7 |
| 2049980-18-7 | Azelaprag;(2S,3R)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide | C25H29N7O4S |
| 2050017-52-0 | (2S,3R)-3-(5-Methylpyrimidin-2-yl)butane-2-sulfonamide | C9H15N3O2S |
| 2050057-56-0 | Upadacitinib hemihydrate;(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo(7.3.0.02,6)dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;hydrate | C34H40F6N12O3 |
| 2051921-49-2 | 2,6-Dichloro-3-fluoropyridin-4-amine | C5H3Cl2FN2 |
| 2054317-97-2 | (R)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine;(1R)-1-(6-(4-fluoropyrazol-1-yl)pyridin-3-yl)ethanamine | C10H11FN4 |
| 2055038-63-4 | Efinaconazole N-Oxide Impurity 1;(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidene-1-oxidopiperidin-1-ium-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol | C18H22F2N4O2 |
| 2055043-54-2 | tert-Butyl (4R)-4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | C11H20F2N2O2 |
| 2055043-62-2 | tert-Butyl (4S)-4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | C11H20F2N2O2 |
| 2055761-19-6 | (3S,4S)-3-Methyl-2-oxa-8-azaspiro(4.5)decan-4-amine dihydrochloride | C9H20Cl2N2O |
| 2055841-26-2 | 4-Amino-3-fluoro-2-methylbenzonitrile | C8H7FN2 |